July 29, 2021
On July 26, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $64.6 million contract modification to SiO2 Medical Products to increase domestic production of pharmaceutical vials made of hybrid, glass-equivalent materials.
This domestic industrial base expansion effort will allow SiO2 to design, develop, and build a series of three vial production systems in Auburn, Alabama. This effort will increase vial production to 10 million vials per month by July 2024.
Posts
No comments:
Post a Comment